Use of angiogenic lipids for vascularizing tissue

Details Use of angiogenic lipids for vascularizing tissue Use of angiogenic lipids for vascularizing tissue

1996-01-31

1998-05-26

Lilling, Herbert J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 2, 514215, 514223, 514247, 514284, 514285, 514291, 514450, 514547, 424422, 424424, 435 12, 673 1, 673 11, 673 13, 554273, A61K 3800, A61K 3813, A61K 3818, A01N 3702

Patent

active

057564531

ABSTRACT:
There is disclosed a method for vascularizing tissue, a method for improving vascularization of ischemic tissue, and a method for improving the viability of grafted tissue or tissue survival in gradient ischemia of heart, brain or skin, comprising administering locally to the grafted or ischemic tissue or the site of the graft an effective amount of a compound comprising an alk-1-enyl glycerol derivative.

REFERENCES:
patent: 4943560 (1990-07-01), Wigness et al.
patent: 5403833 (1995-04-01), Calne
patent: 5569462 (1996-10-01), Martinson et al.
Foglia et al., Lipids, vol. 23, No. 5, pp. 430-434, "Oxidation of 1-O-(Alk-1-enyl)-2,3-Di-O-Acylglycerols: Models for Plasmalogen Oxidation", 1988.
Ford et al., American Physiological Society, vol. 258, pp. C30-C36, "Activation of myocardial protein kinase C by plasmalogenic diglycerides", 1990.
Ford et al., J. Biol. Chem., vol. 264, No. 23, Issue of Aug. 16, pp. 13818-13824, "Activation of Protein Kinase C by Naturally Occurring Ether-linked Diglycerides", 1989.
Gigg, R., Ether Lipids: Chemistry and Biology, Ed. By Fred Snyder, Chapter V, pp. 87-108, "The Chemical Synthesis of Plasmalogens", 1972.
Hallgren et al., Chemical Abstracts, vol. 80, No. 120255k, p. 382, "Therapeutic substituted alkyl or alkenyl glyceryl ethers", 1974.
Hanahan, D., Etherlipids: Chemistry and Biology,Ed. By Fred Snyder, Chapter II, pp. 25-29, "Ether-linked lipids: Chemistry and Methods of Measurement", 1972.
Knorr et al., J. Chromatography, vol. 526, pp. 303-318, "Simple method for the analysis of glycerol enol ethers derived from plasmalogens in complex lipid mixtures and subsequent determination of the aldehydic components by gas chromatography-mass spectrometry", 1990.
Lin et al., Lipids, vol. 12, No. 7, pp. 620-625, "Composition of O-Alkyl and O-Alk-1-enyl Moieties in the Glycerolipids of the Human Adrenal", 1977.
Seher et al., Thermal Analysis, vol. 3, Proceeding Third ICTA DAVOS, pp. 109-119, "Characterization of Unusual Lipids by Novel Thermoanalytical Techniques", 1971.
Serebryakova et al., Chemical Abstracts, vol. 67, No. 116521h, p. 10964-5, "Synthesis and study of the structure of neutral plasmalogens", 1967.
Slotboom et al., Chemical Abstracts, vol. 67, No. 108166f, p. 108167, On the synthesis of plasmalogens, 1967.
Snyder et al., Cancer Res., vol. 28, pp. 972-978, "The Occurrence and Metabolism of Alyl and Alk-1-enyl Ethers of Glycerol in Transplantable Rat and Mouse Tumors", 1968.
Snyder et al., Cancer Res., vol. 29, pp. 251-257, "Alkyl and Alk-1-enyl Ethers of Glycerol in Lipids from Normal and Neoplastic Human Tissues", 1969.
Su et al., Lipids, vol. 9, No. 3, pp. 208-213, "On the Levels of Alkyl and Alk-1-enyl Glycerolipids in Normal Neoplastic Tissues: A Method of Quantification", 1974.
Touabi et al., Biochim. Biophys. Acta, vol. 202, pp. 486-495, "Lipolysis and Potassium Accumulation in Isolated Fat Cells Effect of Insulin and Lipolytic Agents," 1970.

Affiliated with

Also associated with

Rating

Use of angiogenic lipids for vascularizing tissue does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of angiogenic lipids for vascularizing tissue, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of angiogenic lipids for vascularizing tissue will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1960025